Publications

Publications 10276 - 10300 de 33557

| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {

Titre	DOI
Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine Model S. Albac; M. Medina; D. Labrousse; D. Hayez; D. Bonnot; N. Anzala; F. Laurent; T. Ferry; A. Dublanchet; P. Chavanet; C. Fevre; D. Croisier 2020	10.1128/AAC.01870-19
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients A. Mekinian; C. Comarmond; M. Resche-Rigon; T. Mirault; J.Emmanuel Kahn; M. Lambert; J. Sibilia; A. Neel; P. Cohen; M. Hie; S. Berthier; I. Marie; C. Lavigne; M.Anne Vandenhende; G. Muller; Z. Amoura; H. Devilliers; S. Abad; M. Hamidou; L. Guillevin; R. Dhote; B. Godeau; E. Messas; P. Cacoub; O. Fain; D. Saadoun; F.Takayasu Network 2015	10.1161/CIRCULATIONAHA.114.014321
Efficacy of biologics in psoriasis patients under hemodialysis M. Larquey; C. Girard; E. Sbidian; M.A. Richard; F. Aubin; J.L. Schmutz 2017	10.1684/ejd.2017.3064
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers C. Rossi; J. Gilhodes; M. Maerevoet; C. Herbaux; F. Morschhauser; P. Brice; S. Garciaz; C. Borel; L. Ysebaert; L. Oberic; J. Lazarovici; B. Deau; J. Dupuis; A. Chauchet; J. Abraham; F. Bijou; A. Stamatoullas-Bastard; J.V. Malfuson; C. Golfier; C. Laurent; S. Pericart; A. Traverse-Glehen; S. Kanoun; T. Filleron; R.O. Casasnovas; H. Ghesquieres 2018	10.1002/ajh.25154
Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study A.V.A. Beige; F. Ghiringhelli; J. Vincent; J. Lecuelle; C. Truntzer; W. Farah; F. Borsotti; I. Mazilu; S.M. Ilie 2021	10.1016/j.annonc.2021.08.025
Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review S. Deshayes; S. Georgin-Lavialle; A. Hot; C.A. Durel; E. Hachulla; N. Rouanes; S. Audia; T. Le Gallou; P. Quartier; G. Urbanski; L. Messer; S. Klein; H. de Boysson; B. Bienvenu; G. Grateau; A. Aouba 2018	10.3899/jrheum.170684
EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM P. Peterlin; P. Turlure; P. Chevallier; M.P. Gourin; P.Y. Dumas; S. Thepot; A. Berceanu; S. Park; M.A. Hospital; T. Cluzeau; J.M. Torregrossa-Diaz; L. Devron; R. Sapena; F. Chermat; S. Dimicoli-Salazar; P. Fenaux 2021
Efficacy of deep sedation for patients with intractable electrical storm refractory to anti-arrhythmic drugs R. Martins; J.M. Urien; N. Barbarot; J.M. Sellal; N. Clementy; C. Guenancia; E. Gandjbakhch; J. Duchateau; D. Hamon; L. Champ-Rigot; E. Marijon; R. Garcia; C. De Chillou; F. Sacher; V. Galand 2020
Efficacy of different monotherapies in second-line treatment for small cell lung cancer: a meta-analysis of randomized controlled trials Q. Luo; Z. Wang; S. Li; J. Zhou 2015
Efficacy of emergency medical center use of a protocol during telephone calls to give medical advice related to fever or gastroenteritis: a cluster randomized controlled trial P.G. Reuter; I. Durand-Zaleski; O. Ducros; O. Grignon; I. Megy-Michoux; A. Sourbes; T. Desmettre; N. Javaud; F. Lapostolle; E. Vicaut; F. Adnet 2021
Efficacy of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) Treatments According to the Type of Manifestations Based on Analysis of 376 Patients M. Papo; G. Emmi; F. Schiavon; M. Groh; M.L. Urban; C. Marvisi; J.E. Kahn; A. Sinico; M. Samson; P. Cohen; X. Puechal; L. Mouthon; L. Guillevin; A. Vaglio; B. Terrier 2018
Efficacy of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) Treatments According to the Type of Manifestations Based on Analysis of 376 Patients M. Papo; G. Emmi; F. Schiavon; M. Groh; M.L. Urban; C. Marvisi; J.E. Kahn; A. Sinico; M. Samson; P. Cohen; X. Puechal; L. Mouthon; L. Guillevin; A. Vaglio; B. Terrier 2018
Efficacy of everolimus in poor risk patients: Result of the POORTOR study. B.J. Escudier; S. Abadie-Lacourtoisie; E. Blanc; A. Guillot; F. Priou; H. Mahammedi; A. Thiery-Vuillemin; L. Geoffrois; N. Tubiana-Mathieu; A. Adenis; C. Ferlay; L. Albiges 2015	10.1200/jco.2015.33.7_suppl.488
Efficacy of high-frequency neuronavigated repetitive TMS in auditory verbal hallucinations: a double-blind controlled study in patients with schizophrenia S. Dollfus; N. Jaafari; O. Guillin; B. Trojak; M. Plaze; G. Saba; C. Nauczyciel; M. Larmurier; N. Chastan; V. Meille; M. Krebs; S. Ayache; J. Lefaucheur; A. Razafimandimby; E. Leroux; R. Morello; C. Nathou; O. Etard 2017
Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France A. Elkrief; C. Richard; J. Malo; L. Cvetkovic; M. Florescu; N. Blais; M. Tehfe; M. Messaoudene; A. Gagne; M. Orain; S. Medjebar; D. Wan-Chow-Wah; P. Joubert; C. Labbe; F. Ghiringhelli; B. Routy 2020	10.1016/j.jgo.2020.01.002
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma C. Mignard; A.Deschamps Huvier; A. Gillibert; A.Benedicte Modeste; C. Dutriaux; A. Khammari; M.F. Avril; N. Kramkimel; L. Mortier; P. Marcant; T. Lesimple; C. Gaudy-Marqueste; C. Lesage; L. Machet; F. Aubin; N. Meyer; N. Beneton; G. Jeudy; H. Montaudie; J.P. Arnault; L. Visseaux; S. Trabelsi; M. Amini-adle; E. Maubec; Y. Le Corre; D. Lipsker; E. Wierzbicka-Hainaut; N. Litrowski; A. Stefan; F. Brunet-Possenti; M.T. Leccia; P. Joly 2018	10.1155/2018/1908065
Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma C. Mignard; A. Deschamps-Huvier; A.B. Duval-Modeste; C. Dutriaux; A. Khammari; M.F. Avril; L. Mortier; T. Lesimple; C. Gaudy-Marqueste; C. Lesage; L. Machet; F. Aubin; N. Meyer; B. Benhard; G. Jeudy; H. Montaudie; J.P. Arnault; M.T. Leccia; P. Joly; S.F.D.Oncology R. Soc 2018
Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma C. Mignard; A. Deschamps-Huvier; A.B. Duval-Modeste; C. Dutriaux; A. Khammari; M.F. Avril; L. Mortier; T. Lesimple; C. Gaudy-Marqueste; C. Lesage; L. Machet; F. Aubin; N. Meyer; B. Benhard; G. Jeudy; H. Montaudie; J.P. Arnault; M.T. Leccia; P. Joly; S.F.D.Oncology R. Soc 2018
Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma C. Mignard; A. Deschamps-Huvier; A.B. Duval-Modeste; C. Dutriaux; A. Khammari; M.F. Avril; L. Mortier; T. Lesimple; C. Gaudy-Marqueste; C. Lesage; L. Machet; F. Aubin; N. Meyer; B. Benhard; G. Jeudy; H. Montaudie; J.P. Arnault; M.T. Leccia; P. Joly; S.F.D.Oncology R. Soc 2018
Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study V. Prendki; P. Sergent; A. Barrelet; E. Oziol; E. Beretti; M. Berlioz-Thibal; F. Bouchand; F.A. Dauchy; E. Forestier; G. Gavazzi; C. Ronde-Oustau; J. Stirnemann; A. Dinh 2017	10.1016/j.ijid.2017.05.008
Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study A. Streichenberger; B. Pariente; A. Bozon; N. Arab; A. Amiot; L. Vuitton; M. Tilmant; M. Nachury; R. Altwegg; T. Delasalle; C. Gagniere; B. Gregoire; M. Fumery; P. Wils; P. de Chambrun; X. Hebuterne; B. Pereira; G. Bommelaer; A. Buisson 2018
Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study A. Streichenberger; B. Pariente; A. Bozon; N. Arab; A. Amiot; L. Vuitton; M. Tilmant; M. Nachury; R. Altwegg; T. Delasalle; C. Gagniere; B. Gregoire; M. Fumery; P. Wils; P. de Chambrun; X. Hebuterne; B. Pereira; G. Bommelaer; A. Buisson 2018
Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study I. Scarneciu; S. Bungau; A.M. Lupu; C.C. Scarneciu; O.Gabriel Bratu; O. Martha; D.Mirela Tit; L. Aleya; S. Lupu 2019	10.1016/j.ejps.2019.105067
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count M. Divoux; A. Plocque; M. Sevin; L. Voillat; P. Feugier; A. Guerci-Bresler; F. Girodon; J. Broseus 2020	10.1002/ccr3.3026
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count M. Divoux; A. Plocque; M. Sevin; L. Voillat; P. Feugier; A. Guerci-Bresler; F. Girodon; J. Broseus 2020	10.1002/ccr3.3026, Early Access Date = {JUN 2020

Publications

Pages